Background: The coronavirus disease 2019 (COVID-19) pandemic continues to grow worldwide, and systematic reviews (SRs)/meta-analyses (MAs) on COVID-19 can efficiently guide evidence-based clinical practice. However, SRs/MAs with weaknesses mislead practice pose harm patients, too many useless could confusion waste sources. A “living” overview of aims provide an open, accessible frequently updat...
